Amphastar Pharmaceuticals, Inc. (AMPH)
21.51
-0.09
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
21.51
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Debt to Equity Ratio : 0.8961 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8961 |
| March 31, 2026 | 0.8875 |
| December 31, 2025 | 0.8316 |
| September 30, 2025 | 0.8455 |
| June 30, 2025 | 0.8654 |
| March 31, 2025 | 0.8686 |
| December 31, 2024 | 0.8884 |
| September 30, 2024 | 0.8656 |
| June 30, 2024 | 0.87 |
| March 31, 2024 | 0.9327 |
| December 31, 2023 | 0.9753 |
| September 30, 2023 | 1.130 |
| June 30, 2023 | 0.8973 |
| March 31, 2023 | 0.186 |
| December 31, 2022 | 0.194 |
| September 30, 2022 | 0.2044 |
| June 30, 2022 | 0.2081 |
| March 31, 2022 | 0.2195 |
| December 31, 2021 | 0.2349 |
| September 30, 2021 | 0.2467 |
| June 30, 2021 | 0.1572 |
| March 31, 2021 | 0.1595 |
| December 31, 2020 | 0.1672 |
| September 30, 2020 | 0.1635 |
| June 30, 2020 | 0.1627 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1764 |
| December 31, 2019 | 0.1747 |
| September 30, 2019 | 0.1671 |
| June 30, 2019 | 0.1733 |
| March 31, 2019 | 0.186 |
| December 31, 2018 | 0.151 |
| September 30, 2018 | 0.1603 |
| June 30, 2018 | 0.1641 |
| March 31, 2018 | 0.1399 |
| December 31, 2017 | 0.1413 |
| September 30, 2017 | 0.1465 |
| June 30, 2017 | 0.1389 |
| March 31, 2017 | 0.1118 |
| December 31, 2016 | 0.1146 |
| September 30, 2016 | 0.13 |
| June 30, 2016 | 0.1387 |
| March 31, 2016 | 0.1358 |
| December 31, 2015 | 0.1391 |
| September 30, 2015 | 0.1625 |
| June 30, 2015 | 0.1663 |
| March 31, 2015 | 0.1734 |
| December 31, 2014 | 0.155 |
| September 30, 2014 | 0.1814 |
| June 30, 2014 | 0.186 |
| March 31, 2014 | 0.165 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Supernus Pharmaceuticals, Inc. | 0.039 |
| Liquidia Corp. | 0.9374 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.744B |
| Total Liabilities (Quarterly) | 975.61M |
| Shareholders Equity (Quarterly) | 768.16M |
| Current Ratio | 2.397 |
| Net Debt Paydown Yield | -0.83% |